FDA Investigator Michael T Cyrus
Michael T Cyrus has conducted inspections on 11 sites in 1 countries as of 12 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
12 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Michael T Cyrus:
Aaron J Adler,
Alan P Kurtzberg,
Amanda L Fyles,
Amir Alavi,
Anderson,
Andrea A Branche,
Andrea George, PhD,
Andrew K Haack, PhD,
Angel K Sandhu,
Angele C Smith,
Anh M Lac,
Ashar P Parikh,
Ashley N Queen, PhD,
Barbara J Wilcox, PhD,
Bichsa T Tran,
Binh T Nguyen,
Bryan A Galvez,
Calvin B Koerner,
Carl Lee,
Carla J Lundi,
Carole L Jones,
Carrie A Hughes,
Caryn M Mcnab,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
CDR Ileana Barreto Pettit,
Christopher M Hernandez,
Christopher M Jenner,
Christopher R Czajka,
Crystal Monroy,
Daniel J Roberts,
Darren S Brown,
David G Whitman,
David Serrano,
Deborah A Greco,
Diane Cvan Leeuwen,
Dogbeda F Mackenzie,
Dr. Mark J Seaton, PhD,
Dr. Ralph M Bernstein, PhD,
Dustin R Abaonza,
Eileen A Liu,
Elizabeth Ad Girard,
Emily Shacter,
Eric L Dong, BS,
Esther C Broner, PhD,
Evelyn Wong,
Gabriel M Guevarra,
Gam S Zamil,
Gerald Feldman,
Gerald M Feldman, PhD,
Geraldine H Matining,
Geraldine M Peregrin,
Gerard T Schneider,
Grace Deneke,
Heidy C Perales,
Helen B Ricalde,
Henry K Lau,
Himanshu Gupta, PhD,
Homero W Aguilar,
Hossein Khorshidi, PhD,
Iris C Macinnes,
Ivis L Negron,
James B Arnett,
James R Evans,
James R Fleckenstein,
Jamie L Dion,
Jeanne Fringer, PhD,
Jeff M Uriarte,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jennifer M Gogley,
Jessica L Pressley,
Jessica P Mcalister,
Jinnie Kokiatkulkij,
Joan T Briones,
Joel D Hustedt,
Joey V Quitania,
John A Gonzalez,
John L Stevens,
Jolanna A Norton,
Jose Velez,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Joshua S Hunt,
Katherine E Jacobitz,
Keith P Iams,
Kevin Lee,
Kevin P Foley,
Kham Phommachanh,
Kim Lthomas Cruse,
Kirtida Patel,
Lakecha N Lewis,
Lakisha M Williams,
Lance Mde Souza, MBA,
Lata C Mathew, PhD,
Laurie P Norwood,
Laurimer Kuilan Torres,
LCDR Jennifer H Rhyu,
Lesley K Satterwhite,
Lestine C Webb,
Lillian S Wu,
Lilly O Barton,
Liming Zhang,
Linda F Murphy,
Linda Linh N Adams,
Linda Thai,
Ling Yu L Liu,
Linh Tu,
Mabel M Lee,
Mageet,
Maida Henesian (NMI),
Marcus F Yambot,
Maria C Agpaoa,
Maria C Fermin,
Marie K Kinkade,
Mariza M Jafary,
Mark C Saale,
Mark W Babbitt,
Marsha W Major,
Mary A Millner,
Matthew R Clabeaux,
Michael A Charles,
Michael D Garcia,
Michael Shanks, MS,
Michelle K Cockrell,
Michelle Rfrazier Jessen, PhD,
Miguel A Martinez Perez,
Mihaly S Ligmond,
Min Shanmabel Liu,
Nakesha J Jackson,
Nayan J Patel,
Nicholas L Hunt,
Nicholas Obiri, PhD,
Omotunde O Osunsanmi,
Pearl C Ozuruigbo,
Peter E Baker,
Peter Kessler, PhD,
Philip F Istafanos, DMV, MS,
Rachel C Stanton,
Raymond T Oji,
Rebecca K Olin,
Rebecca Rodriguez,
Rebecca T Davis,
Riley C Myers, PhD,
Robert C Coleman,
Robert C Hoover,
Robert D Tollefsen,
Rochelle A Rolnik,
Rowena S Nguyen,
Rumany C Penn, PharmD,
Sammie P La,
Sandra S Saniga,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Saundrea A Munroe,
Scott N Lim,
Selene T Torres,
Seneca D Toms,
Serge L Beaucage,
Sheilyn H Huang,
Shelley H Beausoleil,
Sherri J Jackson,
Sidney B Priesmeyer,
Sonya L Karsik, RAC,
Srinivas R Chennamaneni, PhD,
Stephanie A Slater, MS,
Stuart W Russell,
Sue Lee Chan,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Teresa T Cain,
Terrance L Thomas,
Thea C Grome,
Thuy T Nguyen, LCDR,
Timothy C Grome,
Timothy T Kapsala,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Vashti E Bocker,
Vickie L Anderson,
Virgilio F Pacio, CSO,
Virginia Carroll, PhD,
Walden H Lee,
William V Millar,
Xiaohui Shen,
Yasamin Ameri,
Yi Wang, PhD,
Yvette Mlacour Davis,
Yvins Dezan,
Yvonne Y Wu,
Zachary L Miller,
Zachary L Stamm
Michael T Cyrus's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2020 | FDA 483 | Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy - Form 483, 2020-02-20 |
April, 2022 | FDA 483 | Abraxis BioScience, LLC - Form 483, 2022-04-06 |
November, 2023 | FDA 483 | Paklab - Form 483, 2023-12-08 |
May, 2021 | FDA 483 | Ajinomoto Althea, Inc. - Form 483, 2021-05-25 |
June, 2022 | FDA 483 | TOLMAR, INC. - Form 483, 2022-06-17 |
January, 2024 | FDA 483 | McGuff Pharmaceuticals, Inc. - Form 483, 2024-01-26 |
November, 2022 | FDA 483 | B Braun Medical Inc - Form 483, 2022-11-22 |
March, 2024 | FDA 483 | Amphastar Pharmaceuticals, Inc. - Form 483, 2024-03-01 |
June, 2024 | FDA 483 | Jubilant HollisterStier LLC - Form 483, 2024-06-06 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more